Innate Pharma S.A.
IPHANASDAQ
Healthcare
Biotechnology
$1.37
+0.02(1.5%)
52W $1.17 – $2.44
Quick:
SCHEDULE 13G/A
Mar 4, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13D/A
Feb 6, 2026 (1 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
SCHEDULE 13G/A
Oct 21, 2025 (5 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active